title: Commentary: treatment of femoropopliteal in-stent restenosis for patients with diabetes: do we have an answer to the DEBATE?
authors: 1 Division of Cardiology, University of Colorado, Denver, Colorado, USA.
authors: Ehrin J
authors: EJ
authors: Armstrong
authors: John R
authors: JR
authors: Laird
mesh_terms: D000800:Angioplasty, Balloon / Q000295:instrumentation*; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D020099:Coated Materials, Biocompatible; D003925:Diabetic Angiopathies / Q000628:therapy*; D005260:Female; D005263:Femoral Artery; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage*; D058729:Peripheral Arterial Disease / Q000628:therapy*; D011150:Popliteal Artery; D062666:Vascular Access Devices
chemical_list: D002317:Cardiovascular Agents; D020099:Coated Materials, Biocompatible; D017239:Paclitaxel